11/26/2012 - 10:34am

Ranbaxy Labs has launched a new treatment for acne under a licensing agreement with a Canadian drug maker.

11/21/2012 - 7:55am

The Food and Drug Administration on Wednesday announced the approval of Novartis' Flucelvax, the first seasonal influenza vaccine licensed in the United States produced using cultured animal cells, instead of fertilized chicken eggs.

11/20/2012 - 3:39pm

Canadian regulators have allowed the approval process for a generic opioid painkiller to go forward despite objections from provincial and other authorities, according to published reports.

11/19/2012 - 3:20pm

The drug-discovery division of the Cystic Fibrosis Foundation is teaming up with drug maker Pfizer to find new treatments for patients with the most common genetic mutation of the disease.

11/19/2012 - 1:32pm

The Food and Drug Administration has approved a drug for a condition that can complicate treatment for hepatitis C.

11/19/2012 - 11:14am

The American Cancer Society on Friday honored 19 companies, including three retail pharmacy operators and three consumer packaged goods companies, with its Excellence in Philanthropy award — recognizing the companies for their generous support of the society’s efforts to eliminate cancer as a public health burden.

11/19/2012 - 10:44am

Drug maker Shire has started a research program focused on rare diseases and their effects on patients and healthcare professionals, the company said Monday.

11/16/2012 - 1:54pm

The Federal Trade Commission has approved a deal by Valeant Pharmaceuticals International to buy a Scottsdale, Ariz.-based drug maker.

11/15/2012 - 5:33pm

The Food and Drug Administration has approved a generic drug for leukemia made by a subsidiary of Par Pharmaceutical Cos.